A Phase 4 interventional study of Topical TRanexamic Acid and Placebo in Distal Radius Fractures, sponsored by University Health Network, Toronto. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.
Sponsored by University Health Network, Toronto · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Wrist Fractures with a site in Canada — 4 open to participants now, 4 under way, none of them phase 3. Wrist Fractures · Canada.
Among the 22 studies in Wrist Fractures with a site in Canada, this one is the 9th largest by planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2025, is one of 4 in phase 4, and was the 21st registered.
331 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.
Browse Wrist Fractures studies →4 of the 22 studies in Wrist Fractures with a site in Canada are open now. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 19+ · Healthy volunteers
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 18–80
University of Calgary · Sites in Canada
Ages 14–120
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 41 Wrist Fractures studies recruiting now, 20 (49%) set no upper age limit and 13 (32%) stop at 75 or younger; 7 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 64 across 266 interventional studies indexed under Wrist Fractures.
Median enrollment 74 across the 19 interventional studies, 319 across the 3 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 22 has an industry lead sponsor. The 10 most frequent:
University Health Network, Toronto is the lead sponsor of 1,441 studies on the registry; 298 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.
University Health Network, Toronto has 1 study filed under Wrist Fractures — fewer than ten, so there is no comparison to draw.
3 of the studies in Wrist Fractures with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06384456University Health Network, TorontoTopical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation | 2026-12 |
| NCT04370626University of CalgaryThe Canadian Prospective Pragmatic Perilunate Outcomes Trial | 2026-12-31 |
| NCT06453447University of British ColumbiaPrednisone for CRPS in Distal Radius Fracture | 2027-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 22 studies in Wrist Fractures with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this study is to find out whether the use of topical tranexamic acid (TXA) into the surgical wound will result in less post-operative pain, less pain killer use, and better post-operative use of the wrist in people undergoing surgery for a wrist fracture compared to not using topical TXA (placebo).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
10mL of 100mg/mL TXA in addition to the standard care
Drug: Topical TRanexamic Acid
10mL of 100mg/mL normal saline in addition to the standard care
Drug: Placebo
10mL of 100mg/mL TXA will be administered into the surgical wound prior closure.
10mL of 100mg/mL normal saline will be administered into the surgical wound prior closure.
acute post-op pain
It will be assessed with VAS 0 to 10cm, with higher score indicating worse pain.
Time frame: 24 hours to 72 hours postoperatively
opioid use
Opioid use will be recorded on patients' medication diary
Time frame: 1, 2, and 6-week post-surgery
persistent pain
It will be assessed with VAS 0 to 10cm, with higher score indicating worse pain.
Time frame: 1, 2, and 6-week post-surgery
unscheduled hand-related procedures
clinic/emergency unit visits or any issue or events related to the condition that might lead participant to visit the emergency room, be seen by a doctor, or undergo any intervention more frequently than the usual visits
Time frame: 1, 2, and 6-week post-surgery
Patient reported function
will be assessed using the disabilities of the arm, shoulder and hand questionnaire (DASH) score 0 to 100, with higher score indicating more disability.
Time frame: 1, 2, and 6-week post-surgery
Plan to share: Undecided
Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tranexamic Acid
University Health Network, Toronto →